Erlanger Health

Erlanger Health is a corporate entity registered with SAM.gov as a tax-exempt, non-profit organization and hospital. The organization provides a range of healthcare services through federal grant sub-awards, focusing on specialized medical programs and community health initiatives. Erlanger Health's federal grant activities span areas such as genetic screening, early intervention services for children with disabilities, and cardiovascular health improvement programs. The entity's SAM.gov registration is current, having been registered on May 24, 2023, with an expiration date of June 5, 2025.

Erlanger Health has been involved in several significant federal grant sub-award projects. These include genetic and sickle cell screening, testing, counseling, education, and follow-up services in partnership with the Tennessee Department of Health. The organization also provides early intervention services for children with developmental disabilities from birth to five years old, working with the State of Tennessee under Part C of the Individuals with Disabilities Education Act (IDEA). Erlanger Health participates in Medicaid services, offering advocacy and outreach during the COVID-19 unwinding period in collaboration with the Tennessee Department of Finance & Administration. Additionally, the organization is part of the Tennessee Heart Health Network, a statewide initiative to improve cardiovascular health care quality and outcomes, particularly focusing on hypertension control and smoking cessation. This project is conducted in partnership with the University of Tennessee. Erlanger Health also engages in a project referred to as "RMCC" with the Tennessee Department of Health, though specific details about this program are not provided in the available information.